Notice: This company has been marked as potentially delisted and may not be actively trading. Reneo Pharmaceuticals (RPHM) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Reneo Pharmaceuticals (NASDAQ:RPHM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$993,097.95Number OfInsiders Selling(Last 12 Months)0 Get RPHM Insider Trade Alerts Want to know when executives and insiders are buying or selling Reneo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RPHM Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Reneo Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/24/2024Braden Michael LeonardMajor ShareholderBuy29,600$1.41$41,736.00 9/17/2024Braden Michael LeonardMajor ShareholderBuy55,300$1.36$75,208.00 8/13/2024Braden Michael LeonardMajor ShareholderBuy171,339$1.39$238,161.21 5/14/2024Braden Michael LeonardMajor ShareholderBuy414,281$1.54$637,992.74 (Data available from 1/1/2013 forward) RPHM Insider Trading Activity - Frequently Asked Questions Who is on Reneo Pharmaceuticals's Insider Roster? The list of insiders at Reneo Pharmaceuticals includes Ashley Hall, Braden Michael Leonard, Holdings A/S Novo, Michael Cruse, and Niall O'donnell. Learn more on insiders at RPHM. What percentage of Reneo Pharmaceuticals stock is owned by insiders? 17.90% of Reneo Pharmaceuticals stock is owned by insiders. Learn more on RPHM's insider holdings. Which Reneo Pharmaceuticals insiders have been buying company stock? The following insiders have purchased RPHM shares in the last 24 months: Braden Michael Leonard ($993,097.95), and Niall O'donnell ($1,000,000.00). How much insider buying is happening at Reneo Pharmaceuticals? Insiders have purchased a total of 795,520 RPHM shares in the last 24 months for a total of $1,993,097.95 bought. Which Reneo Pharmaceuticals insiders have been selling company stock? The following insiders have sold RPHM shares in the last 24 months: Ashley Hall ($98,125.00), and Holdings A/S Novo ($710,000.00). How much insider selling is happening at Reneo Pharmaceuticals? Insiders have sold a total of 115,625 Reneo Pharmaceuticals shares in the last 24 months for a total of $808,125.00 sold. More Insider Trading Tools from MarketBeat Related Companies FATE Insider Trading BNTC Insider Trading BMEA Insider Trading ZNTL Insider Trading AMRN Insider Trading TRVI Insider Trading SLDB Insider Trading TCRX Insider Trading STRO Insider Trading LXEO Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:RPHM) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reneo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
